 |
|
Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials
Gwan Gyu Song, Sang-Cheol Bae, Young Ho Lee
Korean J Intern Med. 2014;29(5):656-663. Published online 2014 Aug 28 DOI: https://doi.org/10.3904/kjim.2014.29.5.656
|
|
Citations to this article as recorded by
 Meta-Analysis of Life Cycle Assessment Studies for Polyethylene Terephthalate Water Bottle System
Yoo-Jin Go, Dong-Ho Kang, Hyun-Jin Park, Jun-Hyuk Lee, Jin-Kie Shim
Sustainability.2024; 16(2): 535. CrossRef Actualización de las guías del tratamiento farmacológico de la artritis reumatoide del Colegio Mexicano de Reumatología 2018
Mario H. Cardiel, Sandra Carrillo, Marcela Pérez, Lilia Andrade, César Pacheco Tena, Luis H. Silveira, Leonardo Limón, Sergio Cerpa, Sergio Gutiérrez Ureña, Sergio Durán, Fedra Irazoque Palazuelos, Sandra Muñoz López, Sandra Araceli Sicsik Ayala, Leonor B
Reumatología Clínica.2021; 17(4): 215. CrossRef Update of the Mexican College of Rheumatology guidelines for the pharmacological treatment of rheumatoid arthritis, 2018
Mario H. Cardiel, Sandra Carrillo, Marcela Pérez, Lilia Andrade, César Pacheco Tena, Luis H. Silveira, Leonardo Limón, Sergio Cerpa, Sergio Gutiérrez Ureña, Sergio Durán, Fedra Irazoque Palazuelos, Sandra Muñoz López, Sandra Araceli Sicsik Ayala, Leonor B
Reumatología Clínica (English Edition).2021; 17(4): 215. CrossRef Comparative efficacy and safety of 15 and 30 mg upadacitinib administered to patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
G. G. Song, Y. H. Lee
Zeitschrift für Rheumatologie.2020; 79(1): 103. CrossRef Comparison of the efficacy and safety of tofacitinib and filgotinib in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Y. H. Lee, G. G. Song
Zeitschrift für Rheumatologie.2020; 79(6): 590. CrossRef Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis
Young Ho Lee, Gwan Gyu Song
Zeitschrift für Rheumatologie.2020; 79(8): 785. CrossRef Comparison of the efficacy and safety of tofacitinib and peficitinib in patients with active rheumatoid arthritis: A Bayesian network meta‐analysis of randomized controlled trials
Young Ho Lee, Gwan Gyu Song
International Journal of Rheumatic Diseases.2020; 23(7): 868. CrossRef Optimising Response to Advanced Therapies in Rheumatoid Arthritis – Using
Prehabilitation to Improve Success?
Alice Mason, Mariam Malik, Christopher Edwards
EMJ Rheumatology.2020; : 87. CrossRef N-acetyl-l-cysteine controls osteoclastogenesis through regulating Th17 differentiation and RANKL in rheumatoid arthritis
Hae-Rim Kim, Kyoung-Woon Kim, Bo-Mi Kim, Kyung-Ann Lee, Sang-Heon Lee
The Korean Journal of Internal Medicine.2019; 34(1): 210. CrossRef Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets—A Focus on the JAK-STAT Pathway
Fausto Salaffi, Giovanni Giacobazzi, Marco Di Carlo
Pain Research and Management.2018; 2018: 1. CrossRef An overview of meta-analysis for clinicians
Young Ho Lee
The Korean Journal of Internal Medicine.2018; 33(2): 277. CrossRef Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease‑modifying anti‑rheumatic drugs: A meta‑analysis of randomized controlled trials
Zhi‑Peng Wu, Pei Zhang, Jian‑Zhong Bai, Yuan Liang, Jin‑Shan He, Jing‑Cheng Wang
Experimental and Therapeutic Medicine.2018;[Epub] CrossRef Biologic Therapies for Autoimmune and Connective Tissue Diseases
Rachel M. Wolfe, Dennis C. Ang
Immunology and Allergy Clinics of North America.2017; 37(2): 283. CrossRef Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis
Kyoung-Woon Kim, Bo-Mi Kim, Kyung-Ann Lee, Sang-Heon Lee, Gary S. Firestein, Hae-Rim Kim
Scientific Reports.2017;[Epub] CrossRef 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Susan M. Goodman, Bryan Springer, Gordon Guyatt, Matthew P. Abdel, Vinod Dasa, Michael George, Ora Gewurz‐Singer, Jon T. Giles, Beverly Johnson, Steve Lee, Lisa A. Mandl, Michael A. Mont, Peter Sculco, Scott Sporer, Louis Stryker, Marat Turgunbaev, Barry
Arthritis Care & Research.2017; 69(8): 1111. CrossRef 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Susan M. Goodman, Bryan Springer, Gordon Guyatt, Matthew P. Abdel, Vinod Dasa, Michael George, Ora Gewurz‐Singer, Jon T. Giles, Beverly Johnson, Steve Lee, Lisa A. Mandl, Michael A. Mont, Peter Sculco, Scott Sporer, Louis Stryker, Marat Turgunbaev, Barry
Arthritis & Rheumatology.2017; 69(8): 1538. CrossRef 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
Susan M. Goodman, Bryan Springer, Gordon Guyatt, Matthew P. Abdel, Vinod Dasa, Michael George, Ora Gewurz-Singer, Jon T. Giles, Beverly Johnson, Steve Lee, Lisa A. Mandl, Michael A. Mont, Peter Sculco, Scott Sporer, Louis Stryker, Marat Turgunbaev, Barry
The Journal of Arthroplasty.2017; 32(9): 2628. CrossRef Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors
Christina Gavegnano, Jessica H. Brehm, Franck P. Dupuy, Aarthi Talla, Susan Pereira Ribeiro, Deanna A. Kulpa, Cheryl Cameron, Stephanie Santos, Selwyn J. Hurwitz, Vincent C. Marconi, Jean-Pierre Routy, Laurent Sabbagh, Raymond F. Schinazi, Rafick Pierre S
PLOS Pathogens.2017; 13(12): e1006740. CrossRef Rheumatoide Arthritis
Urspeter Masche
pharma-kritik.2017;[Epub] CrossRef Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials
Young Ho Lee, Sang-Cheol Bae, Gwan Gyu Song
Rheumatology International.2015; 35(12): 1965. CrossRef Posicionamento sobre o uso de tofacitinibe no algoritmo do Consenso 2012da Sociedade Brasileira de Reumatologia para o tratamento da artrite reumatoide
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Cleandro Pires de Albuquerque, Deborah Pereira Gonçalves, Ieda Maria Magalhães Laurindo, Ivanio Alves Pereira, Jozélio Freire de Carvalho, Geraldo da Rocha Castelar Pinheiro, Manoel Barros Bertolo, Maria Ra
Revista Brasileira de Reumatologia.2015; 55(6): 512. CrossRef Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib
Licia Maria Henrique da Mota, Bóris Afonso Cruz, Cleandro Pires de Albuquerque, Deborah Pereira Gonçalves, Ieda Maria Magalhães Laurindo, Ivanio Alves Pereira, Jozélio Freire de Carvalho, Geraldo da Rocha Castelar Pinheiro, Manoel Barros Bertolo, Maria Ra
Revista Brasileira de Reumatologia (English Edition).2015; 55(6): 512. CrossRef Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?
Seung-Ki Kwok
The Korean Journal of Internal Medicine.2014; 29(5): 577. CrossRef
|